-
| Sector | Healthcare |
|---|---|
| Industry | Diagnostics & Research |
| Exchange | NASDAQ |
| CurrencyCode | USD |
| ISIN | US09076W1099 |
| Beta | 3.47 |
|---|---|
| Market Cap | 9M |
| PE Ratio | None |
| Target Price | 6 |
| Dividend Yield | None |
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BIAF using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025